Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 202
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
Molecular radiotherapy: Intracellular targets and delivery
Katherine A Vallis
Univ. of Oxford, Oxford, United Kingdom
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
Nanotechnology In Radiation Oncology
Andrew Z. Wang
University of North Carolina at Chapel Hill, Durham, NC, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
Conventional and Pretargeted Radioimmunotherapy for B Cell Lymphomas
Damian Green
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Antibodies and Nanoparticles for Targeted Radiotherapy to Cancer
AntibodiesTargeted to Radiation Inducible Antigens in Cancer
Dennis E. Hallahan
Washington University School of Medicine, St. Louis, MO, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
CRISPR-Cas Genome-Editing Nucleases: Introduction and Applications
General introduction to CRISPR-Cas9 and strategies to enhance homology-directed repair
Prashant Mali
University of California, San Diego, La Jolla, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
CRISPR-Cas Genome-Editing Nucleases: Introduction and Applications
Altering and improving the specificities of CRISPR-Cas9 nucleases
Benjamin P Kleinstiver
Massachusetts General Hospital, Charlestown, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
CRISPR-Cas Genome-Editing Nucleases: Introduction and Applications
Genome-wide screens using libraries of CRISPR-Cas9 nucleases
Christopher R. Vakoc
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Cancer Metabolism and Immunometabolism: Metabolic Decisions in Oncology
Understanding and exploiting metabolic flexibility in cancer cells
Christian Metallo
UCSD, La Jolla, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Cancer Metabolism and Immunometabolism: Metabolic Decisions in Oncology
Metabolic reprogramming mechanisms
Heather R. Christofk
UCLA School of Medicine, Institute for Molecular Medicine, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Cancer Metabolism and Immunometabolism: Metabolic Decisions in Oncology
Mapping metabolicdrivers of cancer using chemoproteomic and metabolomic platforms
Daniel Nomura
University of California, Berkeley, Berkeley, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Cancer Metabolism and Immunometabolism: Metabolic Decisions in Oncology
Innate immune: Microbiome interactions in cachexia
Janelle Ayres
Salk Institute for Biological Studies, La Jolla, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Clinical Trials Design Methods Workshop, Part 1: New Frontiers for the Design and Conduct of Efficient Cancer Clinical Trials
The evolution of early phase oncology trials - Challenges and solutions: An industry perspective
Chris H. Takimoto
Forty Seven, Inc, Palo Alto, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Clinical Trials Design Methods Workshop, Part 1: New Frontiers for the Design and Conduct of Efficient Cancer Clinical Trials
Novel designs for identifying effective therapies early and the use of dose expansion cohorts in Phase I trials
Alexia Iasonos
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Clinical Trials Design Methods Workshop, Part 1: New Frontiers for the Design and Conduct of Efficient Cancer Clinical Trials
Integrating multiple omics information in the era of precision oncology
Yu Shyr
Vanderbilt-Ingram Cancer Center, Nashville, TN, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Clinical Trials Design Methods Workshop, Part 1: New Frontiers for the Design and Conduct of Efficient Cancer Clinical Trials
Barriers to clinical trial enrollment and how to overcome them
Neal J. Meropol
University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Cohesion and Cancer
Cohesin and human disease: The challenge of connecting molecular function to pathology
Jennifer Gerton
Stowers Institute for Medical Research, Kansas City, MO, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Cohesion and Cancer
Cohesin gene mutations in tumorigenesis: From discovery to clinical significance
David A. Solomon
University of California, San Francisco, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Cohesion and Cancer
The dose dependent role of cohesin in normal hematopoiesis and leukemic transformation
Aaron Viny
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Computational Cancer Epigenomics
Genome-scale analysis of DNA methylation in cancer: Discoveries, challenges, and opportunities
Hui Shen
Van Andel Research Inst., Grand Rapids, MI, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Computational Cancer Epigenomics
Prioritizing non-coding variants in cancer genomes using epigenetic profiles
Peter J. Park
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Computational Cancer Epigenomics
Modeling cancer gene regulation with public ChIP-seq profiles
X Shirley Liu
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Forefront Imaging Techniques in Translational Research
Global quantification oftissue architecture: Combining optical projection tomography and confocalmicroscopy to deliver tissue- and cellular-level information
Alexander Combes
University of Melbourne, Melbourne, Australia
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Forefront Imaging Techniques in Translational Research
Intravital imaging of cell activities in thetumor microenvironment
Mikala Egeblad
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Forefront Imaging Techniques in Translational Research
High content and information-rich screening strategies
Steve Bagley
CRUK Manchester Institute, United Kingdom
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Forefront Imaging Techniques in Translational Research
Interferometric approaches for nanoscale imagingof the cancer cell gycocalyx and associated signaling machinery
Matthew Paszek
Cornell Univ., Ithaca, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 202